“…In contrast to a well-established sensory gating deficit in schizophrenia (Adler et al, 1982;Braff and Geyer, 1990;Freedman et al, 1991;Light and Braff, 1999), results on P50 suppression in patients with Alzheimer's disease have been contradictory (Ally et al, 2006;Cancelli et al, 2006;Fein et al, 1994;Jessen et al, 2001;Thomas et al, 2010). Since the mid-latency P50 component is highly sensitive to filter parameters (Chang et al, 2012;de Wilde et al, 2007;Freedman et al, 1998;Gmehlin et al, 2011;Jerger et al, 1992;Light and Braff, 1998;Patterson et al, 2008), in order to evaluate the validity of P50 as a biomarker for Alzheimer's disease, the effect of filtering on P50 sensory gating measures should be considered.…”